Business High insulin prices spur a federal lawsuit against three pharmacy benefit managers TOM MURPHY 21/09/2024
Business Limits to anti-nausea pill coverage wear on cancer patients and doctors TOM MURPHY 10/09/2024
Business Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter TOM MURPHY 08/08/2024
Business CVS Health cuts its 2024 forecast a third time, dragged down by health insurance struggles TOM MURPHY 07/08/2024
Business Drugstores tinker with new looks as their usual way of doing business faces challenges TOM MURPHY 04/08/2024
Business European committee says Alzheimer’s treatment Leqembi shouldn’t get marketing approval TOM MURPHY 26/07/2024
Business UnitedHealth has a strong second quarter, but cyberattack keeps it cautious on outlook for the year TOM MURPHY 16/07/2024
Business Walgreens to take a hard look at underperforming stores, could shutter hundreds more TOM MURPHY 27/06/2024
Business Drug shortages keep on growing. Older, injectable medicines are among the most vulnerable TOM MURPHY 17/06/2024
Business Biden administration seeks to wipe consumer medical debt off most credit reports with proposed rule TOM MURPHY 12/06/2024
Business Being a patient is getting harder in a strained and complex US health care system TOM MURPHY 02/06/2024
Business Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro TOM MURPHY 24/05/2024
Business Aetna agrees to settle lawsuit over fertility coverage for LGBTQ+ customers TOM MURPHY 04/05/2024
Business Change Healthcare cyberattack was due to a lack of multifactor authentication, UnitedHealth CEO says TOM MURPHY 02/05/2024
Business CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist TOM MURPHY 01/05/2024
Business Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues TOM MURPHY 30/04/2024
Business Cyberattack costs hit UnitedHealth in 1Q that still turns out better than expected TOM MURPHY 16/04/2024
Business It’s the first drug shown to slow Alzheimer’s. Why is is it off to a slow start? TOM MURPHY 13/04/2024
Business J&J to pump another $13B into its MedTech business with Shockwave deal TOM MURPHY 05/04/2024